Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Corneal collagen cross‐linking for infectious keratitis

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD013001Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 30 mayo 2018see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Salud ocular y de la visión

Copyright:
  1. Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Robert A Copeland Jra

    Ophthalmology, Howard University Hospital, Washington, USA

    Deceased

  • Shadi A Davis

    Correspondencia a: Ophthalmology, Howard University Hospital, Washington, USA

    [email protected]

  • Young‐Joo Lee

    Louis Stokes Health Sciences Library, Howard University, Washington, USA

  • John Kwagyan

    General Clinical Research Center, Howard University, Washington, USA

  • Renee Bovelle

    Envision Eye & Laser Center, Glenn Dale, USA

Contributions of authors

  • Conception and design of study (RAC*)

  • Drafting the review or commenting on it critically for intellectual content (RAC, SAD, RB, JK, YJL)

  • Final approval of the document to be published (SAD, JK, YJL, RB)

*Dr. Robert A Copeland Jr died in April 2016. Dr. Copeland conceived, designed, and drafted the first version of the protocol. The authors have made edits to the protocol beyond his contribution, although the main components (population, interventions, comparisons, and outcomes) are consistent with his inital draft.

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • Cochrane Eyes and Vision US Project, supported by grant 1 U01 EY020522, National Eye Institute, National Institutes of Health, USA.

  • National Institute for Health Research (NIHR), UK.

    • Richard Wormald, Co‐ordinating Editor for Cochrane Eyes and Vision (CEV) acknowledges financial support for his CEV research sessions from the Department of Health through the award made by the National Institute for Health Research to Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology for a Specialist Biomedical Research Centre for Ophthalmology.

    • This protocol was supported by the National Institute for Health Research, via Cochrane Infrastructure funding to the CEV UK editorial base.

    The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS, or the Department of Health.

Declarations of interest

RAC: author deceased; no declarations of interest available
SAD: none
YJL: none
JK: none
RB: none

Acknowledgements

Lori Rosman, Information Specialist for Cochrane Eyes and Vision, created and will execute the electronic search strategies. We thank Barbara Hawkins and Nilo Vincent FlorCruz for providing comments to the protocol.

Version history

Published

Title

Stage

Authors

Version

2020 Jun 17

Corneal collagen cross‐linking for bacterial infectious keratitis

Review

Shadi A Davis, Renee Bovelle, Genie Han, John Kwagyan

https://doi.org/10.1002/14651858.CD013001.pub2

2018 May 30

Corneal collagen cross‐linking for infectious keratitis

Protocol

Robert A Copeland Jr, Shadi A Davis, Young‐Joo Lee, John Kwagyan, Renee Bovelle

https://doi.org/10.1002/14651858.CD013001

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.